TY - JOUR
T1 - Structural covariance network topology in individuals at clinical high risk for psychosis
T2 - the ENIGMA-CHR Study
AU - Liu, Siwei
AU - Agartz, Ingrid
AU - Allen, Paul
AU - Amminger, G Paul
AU - Andreassen, Ole A
AU - Bachman, Peter
AU - Baeza, Inmaculada
AU - Baldwin, Helen
AU - Bartholomeusz, Cali F
AU - Borgwardt, Stefan
AU - Catalano, Sabrina
AU - Chen, Xiaogang
AU - Cho, Kang Ik K
AU - Choi, Sunah
AU - Colibazzi, Tiziano
AU - Cooper, Rebecca E
AU - Corcoran, Cheryl M
AU - Cropley, Vanessa L
AU - de Haan, Lieuwe
AU - de la Fuente-Sandoval, Camilo
AU - Dolz, Montserrat
AU - Ebdrup, Bjørn H
AU - Fortea, Adriana
AU - Fusar-Poli, Paolo
AU - ENIGMA Clinical High Risk for Psychosis Working Group
AU - Glenthøj, Louise Birkedal
AU - Glenthøj, Birte Yding
AU - Haas, Shalaila S
AU - Hamilton, Holly K
AU - Haut, Kristen M
AU - Hayes, Rebecca A
AU - He, Ying
AU - Heekeren, Karsten
AU - Hegelstad, Wenche Ten Velden
AU - Hooker, Christine I
AU - Horton, Leslie E
AU - Hubl, Daniela
AU - Hwang, Wu Jeong
AU - Kaess, Michael
AU - Kasai, Kiyoto
AU - Katagiri, Naoyuki
AU - Kim, Minah
AU - Kindler, Jochen
AU - Klaunig, Mallory J
AU - Koike, Shinsuke
AU - Kristensen, Tina D
AU - Kwak, Yoo Bin
AU - Kwon, Jun Soo
AU - Lawrie, Stephen M
AU - Lebedeva, Irina
AU - Lemmers-Jansen, Imke Lj
AU - León-Ortiz, Pablo
AU - Lin, Ashleigh
AU - Loewy, Rachel L
AU - Ma, Xiaoqian
AU - Mathalon, Daniel H
AU - McGorry, Patrick
AU - McGuire, Philip
AU - Michel, Chantal
AU - Mizrahi, Romina
AU - Mizuno, Masafumi
AU - Møller, Paul
AU - Mora-Durán, Ricardo
AU - Muñoz-Samons, Daniel
AU - Nelson, Barnaby
AU - Nemoto, Takahiro
AU - Nordentoft, Merete
AU - Nordholm, Dorte
AU - Omelchenko, Maria A
AU - Ouyang, Lijun
AU - Pantelis, Christos
AU - Pariente, Jose C
AU - Raghava, Jayachandra M
AU - Rasser, Paul E
AU - Resch, Franz
AU - Reyes-Madrigal, Francisco
AU - Rivera-Chávez, Luis F
AU - Røssberg, Jan I
AU - Rössler, Wulf
AU - Salisbury, Dean F
AU - Sasabayashi, Daiki
AU - Schall, Ulrich
AU - Schiffman, Jason
AU - Schmidt, Andre
AU - Smigielski, Lukasz
AU - Sørensen, Mikkel E
AU - Sugranyes, Gisela
AU - Suzuki, Michio
AU - Takahashi, Tsutomu
AU - Tamnes, Christian K
AU - Tang, Jinsong
AU - Theodoridou, Anastasia
AU - Thomopoulos, Sophia I
AU - Tomyshev, Alexander S
AU - Tor, Jordina
AU - Uhlhaas, Peter J
AU - Værnes, Tor G
AU - van Amelsvoort, Therese Amj
AU - Velakoulis, Dennis
AU - Via, Esther
AU - Vinogradov, Sophia
AU - Waltz, James A
AU - Wenneberg, Christina
AU - Westlye, Lars T
AU - Wood, Stephen J
AU - Yamasue, Hidenori
AU - Yuan, Liu
AU - Yung, Alison R
AU - Chee, Michael Wl
AU - Thompson, Paul M
AU - Hernaus, Dennis
AU - Jalbrzikowski, Maria
AU - Lee, Jimmy
AU - Zhou, Juan H
N1 - © 2025. The Author(s).
PY - 2025/10/22
Y1 - 2025/10/22
N2 - Brain network architecture is anticipated to influence future grey matter loss in individuals at Clinical High Risk (CHR) for psychosis. However, existing studies on grey matter structural network properties in CHR are scarce and constrained by small sample sizes. Here, we examined network topology differences comparing a) CHR versus healthy controls (HC); b) CHR who transitioned to psychosis (CHR-T) versus those who did not (CHR-NT); and c) different subsyndromes. We included structural scans from 1842 CHR individuals and 1417 HC individuals from 31 sites within the Enhancing NeuroImaging Genetics through Meta-Analysis (ENIGMA) consortium. At the global level, CHR individuals exhibited lower structural covariance (q < 0.001; Cohen's d = 0.164) and less optimal structural network configuration than HC (lower global efficiency and clustering coefficient, d = 0.100,0.087, qs <= 0.027). Though no global difference between CHR-T and CHR-NT, network distinctiveness of the frontal and temporal surface area networks was higher in CHR-T than CHR-NT (d = 0.223,0.237) and HC (d = 0.208,0.219) (qs < 0.001). Network distinctiveness of the frontal cortical thickness network was lower in CHR-T (d = 0.218, q < 0.001) than CHR-NT and HC (d = 0.165, q < 0.001). Importantly, higher network distinctiveness was associated with worse positive symptoms in CHR-NT (frontal surface area, q = 0.008, R
2 = 0.013) and at trend with worse negative symptoms in CHR-T (frontal thickness, q = 0.063, R
2 = 0.049). Further, the brief intermittent psychotic syndrome subgroup showed more severe network alterations. Together, brain structural networks inform symptoms and the risk of transition to psychosis in CHR individuals.
AB - Brain network architecture is anticipated to influence future grey matter loss in individuals at Clinical High Risk (CHR) for psychosis. However, existing studies on grey matter structural network properties in CHR are scarce and constrained by small sample sizes. Here, we examined network topology differences comparing a) CHR versus healthy controls (HC); b) CHR who transitioned to psychosis (CHR-T) versus those who did not (CHR-NT); and c) different subsyndromes. We included structural scans from 1842 CHR individuals and 1417 HC individuals from 31 sites within the Enhancing NeuroImaging Genetics through Meta-Analysis (ENIGMA) consortium. At the global level, CHR individuals exhibited lower structural covariance (q < 0.001; Cohen's d = 0.164) and less optimal structural network configuration than HC (lower global efficiency and clustering coefficient, d = 0.100,0.087, qs <= 0.027). Though no global difference between CHR-T and CHR-NT, network distinctiveness of the frontal and temporal surface area networks was higher in CHR-T than CHR-NT (d = 0.223,0.237) and HC (d = 0.208,0.219) (qs < 0.001). Network distinctiveness of the frontal cortical thickness network was lower in CHR-T (d = 0.218, q < 0.001) than CHR-NT and HC (d = 0.165, q < 0.001). Importantly, higher network distinctiveness was associated with worse positive symptoms in CHR-NT (frontal surface area, q = 0.008, R
2 = 0.013) and at trend with worse negative symptoms in CHR-T (frontal thickness, q = 0.063, R
2 = 0.049). Further, the brief intermittent psychotic syndrome subgroup showed more severe network alterations. Together, brain structural networks inform symptoms and the risk of transition to psychosis in CHR individuals.
U2 - 10.1038/s41380-025-03304-6
DO - 10.1038/s41380-025-03304-6
M3 - Article
C2 - 41125743
SN - 1359-4184
JO - Molecular Psychiatry
JF - Molecular Psychiatry
ER -